Yayın: The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib
item.page.program
Kurum Yazarları
Yazarlar
Danışman
Tarih
2021-08-01T00:00:00Z
item.page.language
item.page.type
Article
Yayımcı
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
Aim: To show the prognostic significance of the glucose-to-lymphocyte ratio (GLR) in hepatocellular carcinoma (HCC). Patients & methods: A total of 150 patients with advanced HCC who were treated with sorafenib in our center between January 2011 and December 2019 were included in the study retrospectively. Neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index and GLR were analyzed to assess their prognostic value using Kaplan-Meier and Cox regression analysis before and after propensity score matching (PSM). Results: In univariate analysis before and after PSM, albumin-bilirubin grade, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, lymphocyte-to-monocyte ratio, prognostic nutritional index, AFP level and GLR were found to be significantly associated with both progression-free and overall survival. In multivariate analysis before and after PSM, GLR, albumin-bilirubin grade and AFP were determined to be independent prognostic factors for progression-free and overall survival. Conclusion: The GLR prior to sorafenib treatment is a new prognostic biomarker that may predict survival in advanced HCC.
Açıklama
item.page.source
item.page.keywords
Konusu
Alıntı
YILMAZ A., ŞİMŞEK M., HANNARİCİ Z., Buyukbayram M. E. , BİLİCİ M., Tekin S. B. , -The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib-, FUTURE ONCOLOGY, 2021